1. Home
  2. PRSO vs ASBP Comparison

PRSO vs ASBP Comparison

Compare PRSO & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peraso Inc.

PRSO

Peraso Inc.

HOLD

Current Price

$1.18

Market Cap

8.4M

Sector

Technology

ML Signal

HOLD

Logo Aspire Biopharma Holdings Inc.

ASBP

Aspire Biopharma Holdings Inc.

HOLD

Current Price

$2.15

Market Cap

7.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRSO
ASBP
Founded
2008
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4M
7.6M
IPO Year
2001
N/A

Fundamental Metrics

Financial Performance
Metric
PRSO
ASBP
Price
$1.18
$2.15
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
392.9K
1.3M
Earning Date
11-10-2025
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,001,000.00
$1,941.00
Revenue This Year
N/A
N/A
Revenue Next Year
$35.76
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.15
N/A
52 Week Low
$0.52
$1.66
52 Week High
$2.37
$632.00

Technical Indicators

Market Signals
Indicator
PRSO
ASBP
Relative Strength Index (RSI) 65.19 95.30
Support Level $0.93 $0.05
Resistance Level $1.04 $0.10
Average True Range (ATR) 0.07 0.06
MACD 0.02 0.13
Stochastic Oscillator 88.89 95.90

Price Performance

Historical Comparison
PRSO
ASBP

About PRSO Peraso Inc.

Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.

About ASBP Aspire Biopharma Holdings Inc.

Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.

Share on Social Networks: